| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/26/2006 | WO2006055852A1 Methods of developing a stem cell line |
| 05/26/2006 | WO2006055761A1 Methods of determining human egg competency |
| 05/26/2006 | WO2006055615A2 A method for single oxygen atom incorporation into digested peptides using peptidases |
| 05/26/2006 | WO2006055524A2 Biomarkers for diagnosing schizophrenia and bipolar disorder |
| 05/26/2006 | WO2006055521A2 Tirf single molecule analysis and method of sequencing nucleic acids |
| 05/26/2006 | WO2006055501A2 Scoring method for determining pancreas suitability for islet isolation |
| 05/26/2006 | WO2006055453A1 Enzymatic measurement of imatinib mesylate |
| 05/26/2006 | WO2006055338A2 Methods and systems for identifying and isolating stem cells and for observing mitochondrial structure and distribution in living cells |
| 05/26/2006 | WO2006054979A1 Abnormalities of phosphatase 2a (pp2a) for diagnosis and treatment of alzheimer’s disease |
| 05/26/2006 | WO2006054945A1 Methods for assessing the predisposition or susceptibility to copd |
| 05/26/2006 | WO2006054807A1 METHOD OF SITE-SPECIFICALLY TRANSFERRING UNNATURAL AMINO ACID INTO PROTEIN WITH THE USE OF MITOCHONDRIAL PROTEIN AND METHOD OF EFFICIENTLY PREPARING tRNA |
| 05/26/2006 | WO2006054788A1 METHOD OF SCREENING COMPOUND REGULATING THE TRANSLATION OF SPECIFIC mRNA |
| 05/26/2006 | WO2006054770A1 Novel map kinase kinase kinase (mapkkk) |
| 05/26/2006 | WO2006054755A1 Method of screening candidate for drug |
| 05/26/2006 | WO2006054748A1 Remedy for nephritis |
| 05/26/2006 | WO2006054740A1 Nucleic acid fragments for detecting nucleic acid and method of detecting nucleic acid |
| 05/26/2006 | WO2006054722A1 Method of diagnosing the risk of thermolabile phenotype diseases by using gene |
| 05/26/2006 | WO2006054691A1 Soluble protein and utilization of the same |
| 05/26/2006 | WO2006054690A1 Method of detecting gene polymorphism, method of diagnosing, apparatus therefor and test reagent kit |
| 05/26/2006 | WO2006054683A1 Method of detecting antibody with the use of cell-free protein synthesis system and method of screening specific protein |
| 05/26/2006 | WO2006054681A1 Compositions for lipase activity determination and method of determining activity |
| 05/26/2006 | WO2006054449A1 Biomolecule interaction test instrument, biomolecule interaction test method, biomolecule dissolution temperature measuring method, nucleic acid sequence detecting method biomolecule interacting method, and biomolecule mobilizing method |
| 05/26/2006 | WO2006054415A1 In vitro evaluation method for activity of modifying immune response |
| 05/26/2006 | WO2006054333A1 Truncated sialic acid transferase |
| 05/26/2006 | WO2006054297A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 05/26/2006 | WO2006054172A1 Composition for amplifying nucleic acids |
| 05/26/2006 | WO2006054003A1 Method for generating transcripts |
| 05/26/2006 | WO2006053770A1 Real-time pcr of targets on a micro-array |
| 05/26/2006 | WO2006053769A1 Real-time quantification of multiple targets on a micro-array |
| 05/26/2006 | WO2006053725A1 Genic variant of the annexin a5 gene |
| 05/26/2006 | WO2006053463A1 A testing method of nucleic acid binding protein based on biochip |
| 05/26/2006 | WO2006053443A1 Detection of intact recombinant viruses |
| 05/26/2006 | WO2006053442A1 Calml3 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis |
| 05/26/2006 | WO2006053439A1 Hcv f protein and uses thereof |
| 05/26/2006 | WO2006053435A1 Compositions for marking objects with dna and methods for marking and linking an object to its owner |
| 05/26/2006 | WO2006053380A1 Methods of detecting an analyte in a sample |
| 05/26/2006 | WO2006042035A3 Method of monitoring anti-tumor activity of an hdac inhibitor |
| 05/26/2006 | WO2006038794A3 Pmmov resistant capsium plants |
| 05/26/2006 | WO2006036744A3 Methods for a global assay of coagulation and fibrinolysis |
| 05/26/2006 | WO2006033843A3 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 05/26/2006 | WO2006030126A3 Method of accelerating somatic mutations and use thereof in proteomics |
| 05/26/2006 | WO2006019388A3 Cleavable solid phases for isolating nucleic acids |
| 05/26/2006 | WO2006018839A3 Detection of bacteria in fluids |
| 05/26/2006 | WO2006018736A3 Use of golden hamster as infectivity model of sars |
| 05/26/2006 | WO2006018164A3 Fluorescence-based kinetic determination of transglutaminase activity |
| 05/26/2006 | WO2006010369A3 Methods for determining proteins and protein-bound compounds comprising enzymatic modification |
| 05/26/2006 | WO2006008088A3 Secretory phospholipase a2 (spla2) as prognostic and diagnostic marker for cardiovascular diseases |
| 05/26/2006 | WO2006008007A3 Diagnostics and therapeutics for diseases associated with retinoid-inducible serine carboxypeptidase (risc) |
| 05/26/2006 | WO2006004660A3 Detection of mutations in a gene associated with resistance to viral infection |
| 05/26/2006 | WO2006003298A3 Method of determining the mutational load of a gene library obtained by random mutagenesis of a particular gene and means for implementing same |
| 05/26/2006 | WO2006002049A3 Methods for predicting methotrexate polyglutamate levels using pharmacogenetics |
| 05/26/2006 | WO2005123964A3 Susceptibility gene for human stroke: methods of treatment |
| 05/26/2006 | WO2005121370A3 Oligomeric compounds that facilitate risc loading |
| 05/26/2006 | WO2005121369A3 Rna-containing microvesicles and methods therefor |
| 05/26/2006 | WO2005116657A3 Identification of ergothioneine transporter and therapeutic uses thereof |
| 05/26/2006 | WO2005114198A3 Protein phosphorylation assay |
| 05/26/2006 | WO2005113817A3 Aptamer-nanoparticle conjugates and method of use for target analyte detection |
| 05/26/2006 | WO2005111238A3 Aptamer-mediated intracellular delivery of therapeutic oligonucleotides |
| 05/26/2006 | WO2005110067A3 Method and compositions for rna interference |
| 05/26/2006 | WO2005106013A3 Use of mdck cell line to predict corneal penetration of drugs |
| 05/26/2006 | WO2005079533A3 Methods and compositions for mediating gene silencing |
| 05/26/2006 | WO2005075022A3 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment |
| 05/26/2006 | WO2005074633A3 Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 05/26/2006 | WO2005059513A3 Multiplexed electrochemical detection system and method |
| 05/26/2006 | WO2005047472A3 Increasing seed threonine content through alteration of threonine aldolase activity |
| 05/26/2006 | WO2005030998A3 Methods for monitoring gene expression in filamentous fungal cells |
| 05/26/2006 | WO2005028621A3 Assays with primary cells |
| 05/26/2006 | WO2005010494A3 Multiplexed analyte detection |
| 05/26/2006 | WO2004113498A3 Rna interferases and methods of use thereof |
| 05/26/2006 | WO2004084835A3 Treating immunological disorder using agonists of interleukin-21/ interleukin-21 receptor |
| 05/26/2006 | CA2838007A1 A method for single oxygen atom incorporation into digested peptides using peptidases |
| 05/26/2006 | CA2629529A1 Plant extracts and dermatological uses thereof |
| 05/26/2006 | CA2595673A1 Methods of detecting an analyte in a sample |
| 05/26/2006 | CA2588122A1 Tirf single molecule analysis and method of sequencing nucleic acids |
| 05/26/2006 | CA2588072A1 Biomarkers for diagnosing schizophrenia and bipolar disorder |
| 05/26/2006 | CA2588066A1 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 05/26/2006 | CA2588053A1 Method of diagnosing the risk of thermolabile phenotype diseases by using gene |
| 05/26/2006 | CA2587979A1 Method and kit for detecting a risk of essential arterial hypertension |
| 05/26/2006 | CA2587923A1 Genetic variant of the annexin a5 gene |
| 05/26/2006 | CA2587886A1 Method of screening candidate drug |
| 05/26/2006 | CA2587719A1 Method of screening compound regulating the translation of specific mrna |
| 05/26/2006 | CA2587716A1 Hcv f protein and uses thereof |
| 05/26/2006 | CA2587695A1 Scoring method for determining pancreas suitability for islet isolation |
| 05/26/2006 | CA2587419A1 Compositions for marking objects with dna and methods for marking and linking an object to its owner |
| 05/26/2006 | CA2586998A1 Structure-based compound design involving riboswitches |
| 05/26/2006 | CA2586408A1 A testing method of nucleic acid binding protein based on biochip |
| 05/26/2006 | CA2585985A1 Methods of developing a stem cell line |
| 05/26/2006 | CA2585784A1 Methods of determining human egg competency |
| 05/26/2006 | CA2584847A1 Composition for amplifying nucleic acids |
| 05/26/2006 | CA2582270A1 Abnormalities of phosphatase 2a (pp2a) for diagnosis and treatment of alzheimer's disease |
| 05/26/2006 | CA2579478A1 Detection of intact recombinant viruses |
| 05/25/2006 | WO2006008126B1 Novel use of the kinases RSK4 and PAK5 |
| 05/25/2006 | WO2005111622A9 Diagnostic assay for trypanosoma cruzi infection |
| 05/25/2006 | US20060112452 Expression cassettes for seed-preferential expression in plants |
| 05/25/2006 | US20060112437 Transgenic animal expressing alzheimer's tau protein |
| 05/25/2006 | US20060111564 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
| 05/25/2006 | US20060111558 Recombinant infectious laryngotracheitis virus and uses thereof |
| 05/25/2006 | US20060111556 Preventives/remedies for neurodegenerative diseases |
| 05/25/2006 | US20060111551 Peptide having HTLV-1-specific CTL-inducing activity |
| 05/25/2006 | US20060111517 Recognition layers made of hydrogel based on polyacrylamide for use in biosensor technology |